News and Announcements
Soar TGE putting mapping technology on the blockchain: Presale closing soon
- Published October 10, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Soar TGE announces presale closing date to be Wednesday 31 October 2018.
- The world’s first blockchain, mapping technology is offering investors and enthusiasts a 25% discount on SKYM tokens purchased during the presale.
- The Soar platform is partnered with well-known tech companies Alibaba Cloud and the European Space Agency.
Soar TGE has announced its pre-sale closing date will be Wednesday October 31 2018.
The Soar platform will be the first in the world to put mapping technology on the blockchain.
It is designed to offer the international community a decentralised marketplace for high quality drone footage, aerial maps and satellite imagery that connects customers with content creators in a secure, trustless and distributed community leveraging blockchain technology. You can view the public Test Net prototype at demo.soar.earth.
This is now the last chance for investors and enthusiasts to secure a 25% discount on purchases of Soar’s SKYM tokens if they sign up and buy during the presale period. This equals a 33% additional token allocation compared to the public sale.
The Soar platform is partnered with well-known tech companies Alibaba Cloud and the European Space Agency.
About Soar
The Soar platform is designed to offer the international community a decentralised marketplace for high quality drone, aerial and satellite imagery, that connects customers with content creators in a secure, trustless and distributed community leveraging blockchain technology. Soar will very soon be the platform for all future mapping, imagery and geospatial information.
Hobbyist drone operators through to professional organisations will be able to monetise unused content in a marketplace driven by the free market forces of supply and demand.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
